Chromosome 16q24 deletion and decreased E-cadherin expression: Possible association with metastatic potential in prostate cancer

Prostate

Volumn 36, Issue 1, 1998, Pages 31-38

  Pan, Yi ^a   Matsuyama, Hideyasu ^b   Wang, Naming ^a   Yoshihiro, Satoru ^b   Häggarth, Lars ^a   Li, Chunde ^a   Tribukait, Bernhard ^a   Ekman, Peter ^a   Bergerheim, Ulf S R ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

16q24 deletions; E cadherin; Metastases; Prostate cancer

Indexed keywords

DNA; UVOMORULIN;

ARTICLE; BONE METASTASIS; CANCER GRADING; CANCER STAGING; CHROMOSOME 16Q; CHROMOSOME DELETION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; METASTASIS POTENTIAL; PLOIDY; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR;

ADENOCARCINOMA; CADHERINS; CHROMOSOME ABERRATIONS; CHROMOSOME DELETION; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 16; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; NEOPLASM METASTASIS; NEOPLASM STAGING; PLOIDIES; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0032526284     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19980615)36:1<31::AID-PROS5>3.0.CO;2-E     Document Type: Article

References (33)

1. Sandberg AA: Chromosomal abnormalities and related events in prostate cancer. Hum Pathol 1992;23:368-380.
2. Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI, Isaacs WB: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA 1990;87:8751-8755.
3. Bergerheim USR, Kunimi K, Collins VP, Ekman P: Deletion mapping of chromosomes 8, 10 and 16 in human prostatic carcinoma. Genes Chromosomes Cancer 1991;3:215-220.
4. Kunimi K, Bergerheim USR, Larsson IL, Ekman P, Collins VP: Allelotyping of the human prostatic adenocarcinoma. Genomics 1991;11:530-536.
5. Suzuki H, Komiya A, Emi M, Kuramochi H, Shiraishi T, Yatani R, Shimazaki J: Three distinct commonly deleted regions of chromosome arm 16q in human primary and metastatic prostate cancers. Genes Chromosomes Cancer 1996;17:225-233.
6. Cleton-Jansen A, Moerland EW, Kuipers-Dijkshoorn NJ, Callen DF, Sutherland GR, Hansen B, Devilee P, Cornelisse CJ: At least two different regions are involved in allelic imbalance in chromosome arm 16q in breast cancer. Genes Chromosomes Cancer 1994;9:101-107.
7. Tsuda H, Zhang W, Shimosato Y, Yokota J, Terada M, Sugimura T, Miyamura T, Hirohashi S: Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc Natl Acad Sci USA 1990;87:6791-6794.
8. Sato T, Saito H, Morita R, Koi S, Lee JH, Nakamura Y: Allelotype of human ovarian cancer. Cancer Res 1991;51:5118-5122.
9. Natt E, Magenis RE, Zimmer J, Mansouri A, Scherer G: Regional assignment of the human loci for uvomorulin and chymotrypsinogen B with the help of two overlapping deletions on the long arm of chromosome 16. Cytogenet Cell Genet 1989;50:145-148.
10. Koyama K, Emi M, Nakamura Y: The cell adhesion regulator (CAR) gene, TaqI and insertion/deletion polymorphisms, and regional assignment to the peritelomeric region of 16q by linkage analysis. Genomics 1993;16:264-265.
11. Vleminckx K, Vakaet L Jr, Mareel M, Fiers W, van Roy F: Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991;66:107-119.
12. Umbas R, Schalken JA, Aalders TW, Carter BS, Karthaus HFM, Schaafsma HE, Debruyne FMJ, Isaacs WB: Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res 1992;52:5104-5109.
13. Umbas R, Isaacs WB, Breinguier PP, Schaafsma HE, Karthaus HFM, Oosterhof GON, Debruyne FMJ, Schalken JA: Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. Cancer Res 1994;54:3929-3933.
14. Hopman AHN, Voorter CEM, Ramaekers FCS: Detection of genomic changes in cancer by in situ hybridization. Mol Biol Rep 1994;19:31-44.
15. Matsuyama H, Pan Y, Skoog L, Tribukait B, Naito K, Ekman P, Lichter P, Bergerheim USR: Deletion mapping of chromosome 8p in prostate cancer by fluorescence in situ hybridization. Oncogene 1994;9:3071-3076.
16. Matsuyama H, Pan Y, Mahdy EA, Malmström PU, Hedrum A, Uhlen M, Busch C, Hirano T, Auer G, Tribukait B, Naito K, Lichter P, Ekman P, Bergerheim USR: p53 deletion as a genetic marker in urothelial tumor by fluorescence in situ hybridization. Cancer Res 1994;54:6057-6060.
17. Cher ML, Ito T, Weidner N, Carroll PR, Jensen RH: Mapping of regions of physical deletion on chromosome 16q in prostate cancer cells by fluorescence in situ hybridization (FISH). J Urol 1995;153:249-254.
18. Mostofi FK, Sesterhenn I, Sobin LH: Histological typing of prostate tumours. International histological classification of tumours. No. 22. Geneva: World Health Organization, 1980.
19. Hermanek P, Sobin LH: TNM classification of malignant tumours. 4th ed. Berlin, Springer-Verlag, 1987, pp. 124-126.
20. Castro J, Heiden T, Wang N, Tribukait B: Preparation of cell nuclei from fresh tissues for high-quality DNA flow cytometry. Cytometry 1993;14:793-804.
21. Latil A, Cussenot O, Fournier G, Driouch K, Lidereau R: Loss of heterozygosity at chromosome 16q in prostate adenocarcinoma: Identification of three independent regions. Cancer Res 1997;57: 1058-1062.
22. Cher ML, Bova GS, Moore DH, Small EJ, Carroll PR, Pin SS, Epstein JI, Isaacs WB, Jensen RH: Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 1996;5:3091-3102.
23. Kaupmann K, Becker-Follmann J, Scherer G, Jockusch H, Starzinski-Powitz A: The gene for the cell adhesion molecule M-cadherin maps to mouse chromosome 8 and chromosome 16q24.1-qter and is near the E-cadherin (Uvomorulin) locus in both species. Genomics 1992;14:488-490.
24. Lee SW: H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med 1996;2:776-782.
25. Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ, Collins FS: Fusion between transcription factor CBF β/PEBP2 β and a myosin heavy chain in acute myeloid leukemia. Science 1993;261:1041-1044.
26. Bussemakers MJ, van Bokhoven A, Voller M, Smit FP, Schalken JA: The genes of the calcium-dependent cell adhesion molecules P- and E-cadherin are tandemly arranged in the human genome. Biochem Biophys Res Commun 1994;203:1291-1294.
27. Bussemakers MJG, van Moorselaar RJA, Giroldi LA, Ichikawa T, Isaacs JT, Takeichi M, Debruyne FMJ, Schalken JA: Decreased expression of E-cadherin in the progression of rat prostatic cancer. Cancer Res 1992;52:2916-2922.
28. Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Höfler H: E-cadherin gene mutations provide clues to diffuse type gastric carcinomas. Cancer Res 1994;54:3845-3852.
29. Berx G, Cleton-Jansen AM, Nollet F, Leeuw WJF, van de Vijver MJ, Cornelisse C, van Roroy F: E-cadherin is a tumor/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995;14:6107-6115.
30. Risinger J, Berchuck A, Kohler MF, Boyd J: Mutations of the E-cadherin gene in human gynecologic cancers. Nat Genet 1994; 7:98-102.
31. Fowler JE, Whimore WF: The incidence and extent of pelvic lymph node metastases in apparently localized prostate cancer. Cancer 1981;47:2941-2945.
32. McNeal JE, Villers AA, Redwine EA, Freiha FS, Stamey TA: Histologic differentiation, cancer volume, and pelvic node metastasis in adenocarcinoma of the prostate. Cancer 1990;66:1225-1233.
33. van den Ouden D, Tribukait B, Blom J, Fosså S, Kurth K, Fiebo K, Heiden T, Wang N, Schröder F, EORTC Genitourinary Group: Deoxyribonucleic acid ploidy of core biopsies and metastatic lymph nodes of prostate cancer patients treated with early versus delay endocrine treatment. Impact on time to progression. J Urol 1993;150:400-406.